Research that explores the use of umbilical cord blood cells

Duke Medicine received $15 million for research that explores the use of umbilical cord blood cells to treat autism, stroke, cerebral palsy and related brain disorders.

Dr. Joanne Kurtzberg, chief scientific and medical officer of Duke’s Robertson Cell and Translational Therapy Program, and Geraldine Dawson, director of the Duke Center for Autism Diagnosis and Treatment hope to develop cell-based therapies that can potentially restore brain function in people with the disorders, for which there currently are no cures. If successful, the study could identify therapies for further evaluation in clinical trials to potentially decrease disabilities and improve the quality of life for millions of children and adults.

 

Read the full article on bizjournals.com